Head-to-Head arthritis drug study reveals which works better
NCT ID NCT07386717
Summary
This study compared two types of arthritis medications in real-world patients to see which works better for controlling joint pain and skin symptoms. Researchers followed 70 adults with psoriatic arthritis for 24 weeks, comparing upadacitinib pills against IL-17 inhibitor injections. The goal was to help doctors choose the most effective treatment based on actual patient experiences rather than controlled trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University First Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.